Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

British journal of clinical pharmacology

Volumn 78, Issue 4, 2014, Pages 707-717

  Loke, Yoon K ^a   Pradhan, Shiva ^a   Yeong, Jessica K a Yan ^a   Kwok, Chun S hing ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

acute coronary syndrome; apixaban; dabigatran; rivaroxaban

Indexed keywords

ANTITHROMBIN; APIXABAN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN; MORPHOLINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE; RIVAROXABAN; THIOPHENE DERIVATIVE;

ACUTE CORONARY SYNDROME; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COMPARATIVE STUDY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACUTE CORONARY SYNDROME; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; DABIGATRAN; FACTOR XA INHIBITORS; HUMANS; MORPHOLINES; PYRAZOLES; PYRIDONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIVAROXABAN; THIOPHENES;

EID: 84964315181     PISSN: None     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12376     Document Type: Article

References (0)